Beryl Drugs standalone net profit rises 1000.00% in the June 2026 quarter

Sales rise 52.40% to Rs 7.30 crore

Net profit of Beryl Drugs rose 1000.00% to Rs 0.22 crore in the quarter ended June 2026 as against Rs 0.02 crore during the previous quarter ended June 2025. Sales rose 52.40% to Rs 7.30 crore in the quarter ended June 2026 as against Rs 4.79 crore during the previous quarter ended June 2025.

Particulars	Quarter Ended
	Jun. 2026	Jun. 2025	% Var.
Sales	7.30	4.79	52
OPM %	8.90	11.48	-
PBDT	0.59	0.45	31
PBT	0.27	0.07	286
NP	0.22	0.02	1000

Powered by Capital Market - Live News